CancerAid valued at $4.25m after welcoming seed funding from strategic investors
Sydney-based healthtech start-up CancerAid has closed its Seed B funding round at $1.25 million, bringing its total valuation to $4.25 million. Founded in August 2015 by doctors Nikhil Pooviah and Raghav Murali-Ganesh of the Chris O’Brien Lifehouse cancer hospital, the company last month launched an app that manages a patient’s cancer journey, including their treatment and […]